| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Southpoint Capital Advisors LP is a 10% Owner at FENNEC PHARMACEUTICALS INC.. Recent SEC Form 4 filings include 1 buy and 7 sells.
Estimated insider holdings value: $18.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 24, 2025 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Sell | 1,000,000 | $7.50 | $7,500,000.00 | -26.7% | -21.5% | - | |
| Nov 18, 2025 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Sell | 19,341 | $8.79 | $170,048.01 | -0.5% | -0.8% | - | |
| Nov 17, 2025 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Sell | 246,018 | $8.27 | $2,035,625.21 | -3.1% | -0.8% | - | |
| Oct 9, 2025 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Sell | 67,114 | $9.48 | $636,228.85 | -0.6% | -18.5% | - | |
| May 4, 2020 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Buy | 80,000 | $6.25 | $500,000.00 | +2.0% | - | - |